Sepsis is a life-threatening reaction to infection that can quickly damage organs. A new review looks at how the gut and kidneys talk to each other during this crisis. The findings come from studies on both people and animals. They show that sepsis causes the gut bacteria to become unbalanced. This condition is called dysbiosis. When this happens, the protective lining of the intestine weakens. This allows harmful substances to pass into the bloodstream. These substances then travel to the kidneys and cause injury. The review found that kidney function becomes impaired during this process. Specific bacteria known to produce toxins increase in number. At the same time, helpful bacteria decrease. The review also identified specific chemicals that drive kidney inflammation and scarring. These include indoxyl sulfate, p-cresol sulfate, and trimethylamine N-oxide. These chemicals are made by the gut and travel to the kidneys. They promote damage that leads to organ failure. The review notes that this link between the gut and kidney offers new ideas for treatment. It suggests that fixing the gut might help protect the kidneys from sepsis damage. However, the review relies on existing studies rather than new clinical trials. It does not report specific safety data or numbers of patients treated. The evidence comes from a mix of human and animal research. This means the results are promising but not yet ready for immediate clinical use. More research is needed to confirm these findings in large groups of patients.
Gut microbiota dysbiosis and microbial metabolites impair renal function in sepsis-associated acute kidney injurySepsis may damage kidneys by letting gut bacteria toxins leak into the blood
AI-generated summary of the cited source, checked by automated accuracy review. How we work
This narrative review explores the connection between gut microbiota dysbiosis and kidney injury in the context of sepsis. The scope includes human and animal studies regarding the impact of microbial changes on organ function. The authors synthesize findings on how loss of microbial diversity and expansion of pathobionts contribute to disease progression.
The review details compromised intestinal barrier integrity and impaired renal function as key outcomes. Specific microbial signatures include increased Clostridium asparagiforme and decreased Roseburia spp., alongside elevated uremic toxin-producing bacteria like Gordonibacter pamelaeae. These changes are linked to renal inflammation and fibrosis promoted by gut-derived metabolites including indoxyl sulfate, p-cresol sulfate, and trimethylamine N-oxide (TMAO).
The authors note that sepsis induces gut microbiota dysregulation which plays an important role in the development of sepsis-associated acute kidney injury. The practice relevance indicates that intestine-kidney crosstalk may provide a basis for the treatment of sepsis-induced organ injury and also provide new ideas for the treatment of sepsis-associated acute kidney injury. Limitations regarding specific study populations and adverse events were not reported in this source.